« Back to news listing

J&J to Acquire Synthesis & Sell to Biomet, Inc.

J&J’s proposed $21.3 billion acquisition of Synthes, Inc. would illegally reduce competition. J&J intends to sell its system, known as DVR, along with the rest of its product line for treating traumatic injuries, to Biomet, Inc. per FTC requirement for acquisition.

Read entire article: http://www.ftc.gov/opa/2012/06/jjsynthes.shtm

« Back to news listing